Trade Vor Biopharma Inc. - VOR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.37 |
| Open | 1.37 |
| 1-Year Change | -31.5% |
| Day's Range | 1.35 - 1.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 1.35 | -0.01 | -0.74% | 1.36 | 1.39 | 1.35 |
| Feb 20, 2025 | 1.37 | -0.03 | -2.14% | 1.40 | 1.40 | 1.34 |
| Feb 19, 2025 | 1.37 | -0.03 | -2.14% | 1.40 | 1.42 | 1.34 |
| Feb 18, 2025 | 1.40 | 0.03 | 2.19% | 1.37 | 1.47 | 1.36 |
| Feb 14, 2025 | 1.35 | 0.06 | 4.65% | 1.29 | 1.35 | 1.29 |
| Feb 13, 2025 | 1.30 | -0.09 | -6.47% | 1.39 | 1.39 | 1.27 |
| Feb 12, 2025 | 1.35 | 0.05 | 3.85% | 1.30 | 1.35 | 1.26 |
| Feb 11, 2025 | 1.30 | -0.07 | -5.11% | 1.37 | 1.37 | 1.28 |
| Feb 10, 2025 | 1.36 | -0.04 | -2.86% | 1.40 | 1.40 | 1.24 |
| Feb 7, 2025 | 1.38 | -0.11 | -7.38% | 1.49 | 1.52 | 1.37 |
| Feb 6, 2025 | 1.47 | 0.01 | 0.68% | 1.46 | 1.55 | 1.43 |
| Feb 5, 2025 | 1.44 | 0.09 | 6.67% | 1.35 | 1.45 | 1.32 |
| Feb 4, 2025 | 1.36 | 0.04 | 3.03% | 1.32 | 1.39 | 1.31 |
| Feb 3, 2025 | 1.31 | -0.01 | -0.76% | 1.32 | 1.36 | 1.27 |
| Jan 31, 2025 | 1.38 | 0.05 | 3.76% | 1.33 | 1.46 | 1.33 |
| Jan 30, 2025 | 1.36 | -0.04 | -2.86% | 1.40 | 1.41 | 1.32 |
| Jan 29, 2025 | 1.35 | 0.03 | 2.27% | 1.32 | 1.38 | 1.30 |
| Jan 28, 2025 | 1.34 | -0.01 | -0.74% | 1.35 | 1.37 | 1.31 |
| Jan 27, 2025 | 1.36 | -0.03 | -2.16% | 1.39 | 1.51 | 1.30 |
| Jan 24, 2025 | 1.44 | -0.07 | -4.64% | 1.51 | 1.55 | 1.44 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Vor Biopharma Inc. Company profile
About Vor Biopharma Inc
Vor Biopharma Inc is a clinical-stage cell therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solution for patients suffering from hematological malignancies. The Company develops engineered hematopoietic stem cell (eHSC) product candidate, VOR33, VCAR33, which together are the treatment paradigm for acute myeloid leukemia (AML) and other hematological malignancies. The Company’s platform provides treatment for both hematopoietic stem cell transplants and targeted therapies, such as antibody drug conjugates (ADCs), bispecific antibodies and CAR-T cell treatments, including CD33 CAR-T. The Company uses genome engineering technology to remove CD33 surface targets from hematopoietic stem cells (HSCs) to create VOR33. The Company’s eHSCs, such as VOR33, are designed to be used with therapeutics such as VCAR33, that would provide tumor-specific killing.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Vor Biopharma Inc revenues was not reported. Net loss applicable to common stockholders increased 65% to $51.9M. Higher net loss reflects Research and development - Balancing val increase of 67% to $33.2M (expense), General and administrative - Balancing increase from $7M to $14.4M (expense), Stock-based Compensation in R&D increase from $374K to $1.6M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
100 Cambridgepark Drive
Suite 101
CAMBRIDGE
MASSACHUSETTS 02140
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com